Skip to main content
SpringerLink
Log in
Book cover

Dermatology in Five Continents pp 210–217Cite as

Vitiligo

  • Conference paper

  • 145 Accesses

Abstract

Despite much research work, the pathogenesis of vitiligo is still an enigma [36]. The precise mechanism of disappearance of melanocytes resulting in the loss of skin color is unknown. Immunologic factors may play a role as well as genetic neural and chemical factors. It is uncertain whether vitiligo is one disease entity with a specific pathogenesis or if the loss of melanocytes is the final common pathway of several processes. However, during the last past years, definite progresses have been made in the study of this common disorder.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abdel-Fattah A, Aboul Enein MN, Wassel G, El-Menshawi B (1982) An approach to the treatment of vitiligo by Khellin. Dermatologica 165:136–140.

    Article  PubMed  CAS  Google Scholar 

  2. Aronson PJ, Hashimoto K (1987) Association of IgA antimelanoma antibodies in the sera of vitiligo patients with active disease. J Invest Dermatol (abstract) 88:475.

    Google Scholar 

  3. Boissy RE, Lamont SJ, Smyth JR Jr (1984) Persistence of abnormal melanocytes in immunosuppressed chickens of the autoimmune “DAM” line. Cell Tissue Res 235:663–668.

    Article  PubMed  CAS  Google Scholar 

  4. Boissy RE, Moellmann RE, Lerner AB (1987) Morphology of melanocytes in hair bulbs and eyes of vitiligo mice. Am J Pathol 127:380–388.

    PubMed  CAS  Google Scholar 

  5. Boissy RE, Moellmann G, Trainer AT, Smyth JR Jr, Lerner AB (1986) Delayed-amelanotic (DAM or Smyth) chicken: melanocyte dysfunction in vivo and in vitro. J Invest Dermatol 86:149–156.

    Article  PubMed  CAS  Google Scholar 

  6. Bystryn JC, Naughton GK (1985) The significance of vitiligo antibodies. J Dermatol 12:1–9.

    PubMed  CAS  Google Scholar 

  7. Bystryn JC, Rigel D, Friedman RJ, Kopf A (1986) Vitiligo-like hypopigmentation influences favorably the prognosis of melanoma. Presented at the XIIIth Intern Pigment Cell Conference, Tucson, USA.

    Google Scholar 

  8. Calanchini-Postizzi E, Frenk E (1987) Long term actinic damage in sun-exposed vitiligo and normally pigmented skin. Dermatologica 174:266–271.

    Article  PubMed  CAS  Google Scholar 

  9. Chakrabarti SG, Haider R, Johnson BA, Minus HR, Pradhan TK, Kenney JA Jr (1986) 8-Methoxy-psoralen levels in blood of vitiligo patients and in skin, ophthalmic fluids and ocular tissues of the guinea pig. J Invest Dermatol 87:276–279.

    Article  PubMed  CAS  Google Scholar 

  10. Claudy AL, Rouchouse B (1984) Langerhans’ cell and vitiligo: quantitative study of T6 and HLA-DR antigen-expressing cells. Acta Derm Venereol 65:334–336.

    Google Scholar 

  11. Cormane RH, Siddiqui AH (1985) L-Phenylalanine and UVA/sunlight for vitiligo. Arch Dermatol Res 277:509.

    Article  PubMed  CAS  Google Scholar 

  12. Cormane RH, Siddiqui AH, Westerhof W, Schutgens RBH (1985) Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res 277:126–130.

    Article  PubMed  CAS  Google Scholar 

  13. Gowan CL, Haider RM, Grimes PE, Chakrabarti SG, Kenney JA (1986) Ocular disturbances in vitiligo. J Am Acad Dermatol 15:17–24.

    Article  Google Scholar 

  14. Grimes PE, Ghoneum M, Stockton T, Ppayne C, Kelly P, Alfred L (1986) T cell profiles in vitiligo. J Am Acad Dermatol 14:196–201.

    Article  PubMed  CAS  Google Scholar 

  15. Gupta AK, Haberman JHF, Pawlowski D, Shulman G, Menon A (1985) Canthaxanthin. Int J Dermatol 24:528–532.

    PubMed  CAS  Google Scholar 

  16. Haji-Abbasi M, Samsoen M, Grosshans E (1981) Vitiligo et sensibilisation au DNCB en peau achromique. Ann Derm Venereol 108:1023–1025.

    Google Scholar 

  17. Halder RM, Grimes PE, Cowan CA, Enterlin JA, Chakrabarti SG, Kenney JA Jr (1988) Childhood vitiligo. J Am Acad Dermatol (in press).

    Google Scholar 

  18. Halder RM, Walters CS, Johnson BA, Chakrabarti SG, Kenney JA Jr (1986) T lymphocytes and interleukin 2. Activity are decreased in vitiligo. Presented at the XIIIth Intern Pigment Cell Conference, Tucson, USA.

    Google Scholar 

  19. Haider RM, Walters CS, Johnson BA, Chakrabarti SG, Kenney JA Jr (1986) Aberrations in T lymphocytes and natural killer cells in vitiligo: a flow cytometric study. J Am Acad Dermatol 14:733–737.

    Article  Google Scholar 

  20. Hatchome N, Aiba S, Kato T, Torinuki W, Tagami H (1987) Possible functional impairment of Langerhans’ cells in vitiliginous skin. Arch Dermatol 123:51–54.

    Article  PubMed  CAS  Google Scholar 

  21. Hönigsmann H, Ortel B (1985) Khellin photochemotherapy of vitiligo. Photodermatology 2:193–194.

    PubMed  Google Scholar 

  22. Hornung MA, Krementz ET (1974) Specific tissue and tumor responses of chimpanzees following immunization against human melanoma. Surgery 75:477.

    PubMed  CAS  Google Scholar 

  23. Lentz KJ, Burns RP, Loeffler K, Feeney-Burns L, Berkelhammer J, Hook RR (1983) Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression. Invest Ophthalmol Vis Sci 24:1063–1069.

    PubMed  CAS  Google Scholar 

  24. Lerner AB, Cage GW (1973) Melanomas in horses. Yale Y Biol Med 46:646.

    CAS  Google Scholar 

  25. Lerner AB, Nordlund JJ (1978) Vitiligo: the loss of pigment in skin, hair and eyes. J Dermatol 5:1–8.

    PubMed  CAS  Google Scholar 

  26. Lerner AB, Kirkwood JM (1984) Vitiligo and melanoma: can genetically abnormal melanocytes result in both vitiligo and melanoma within a single family? J Am Acad Dermatol 11:696–701.

    Article  PubMed  CAS  Google Scholar 

  27. Lerner AB, Shiohara T, Boissy RE, Jacobson KA, Lamoreux ML, Moellmann GE (1986) A mouse model for vitiligo. J Invest Dermatol 87:299–304.

    Article  PubMed  CAS  Google Scholar 

  28. Lipkin G, Naughton GK, Rosenberg M, Bystryn JC (1985) Vitiligo-related pigment cell differentiation antigens are expressed on malignant melanoma cells following phenotypic reversion induced by contact inhibitory factor. Differentiation 30:35–39.

    Article  PubMed  CAS  Google Scholar 

  29. Mahaffey MB, Yarbrough KM, Munnell JF (1978) Focal loss of pigment in the Belgian Tervuren dog. J Am Vet Med Assoc 173:390–396.

    PubMed  CAS  Google Scholar 

  30. Moellmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB (1982) Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 79:321–330.

    Article  PubMed  CAS  Google Scholar 

  31. Naughton GK, Eisinger M, Bystryn JC (1983) Antibodies to normal human melanocytes in vitiligo. J Exp Med 158:246–251.

    Article  PubMed  CAS  Google Scholar 

  32. Naughton GK, Lipkin G, Bystryn JC (1984) Expression of vitiligo antigen on a revertant line of Hamster melanoma cells. J Invest Dermatol 83:317–319.

    Article  PubMed  CAS  Google Scholar 

  33. Naughton GK, Mahaffey M, Bystryn JC (1986) Antibodies to surface antigens of pigmented cells in animals with vitiligo. Proc Soc Exp Biol Med 181:423–426.

    Article  PubMed  CAS  Google Scholar 

  34. Norris DA, Kissinger RM, Bystryn JC, Naughton GK (1986) Vitiligo patients’ sera induce complement-mediated lysis and ADCC of human melanocytes in vitro. J Invest Dermatol 86:498.

    Google Scholar 

  35. Ortel B, Tanew A, Honigsmann H (1986) Vitiligo treatment. In Curr Probl Derm (Karger Basel) 15:265–271.

    CAS  Google Scholar 

  36. Ortonne JP (1987) Vitiligo, still an enigma? Dermatol 174:261–265.

    Article  CAS  Google Scholar 

  37. Oxen Hangler RW, Berkelhammer J, Smith GD, Hook RR Jr (1982) Growth and regression of cutaneous melanomas in Sinclair miniature swine. Am J Pathol 109:259–269.

    Google Scholar 

  38. Porter JR, Beuf AH, Lerner A, Nordlund J (1986) Psychosocial effects of vitiligo: a comparison of vitiligo patients with “normal” control subjects, with psoriasis patients and with patients with other pigmentary disorders. J Am Acad Dermatol 15:220–224.

    Article  PubMed  CAS  Google Scholar 

  39. Puri N, Ramaiah A, Mojamdar M (1987) In vitro growth characteristics of melanocytes from normal and vitiligo subjects. J Invest Dermatol 88:434–438.

    Article  PubMed  CAS  Google Scholar 

  40. Rheims LA, Palkowski MR, Nordlund JJ (1986) Alterations in cutaneous immune reactivity to Dinitrofluorobenzene in Graying C 57 B1/vi.vi. mice. J Invest Dermatol 86:539–542.

    Article  Google Scholar 

  41. Schallreuter KU, Hordinsky MK, Wood JM (1987) Thioredoxin reductase. Role in free radical reduction in different hypopigmentation disorders. Arch Dermatol 123:615–619.

    Article  PubMed  CAS  Google Scholar 

  42. Schallreuter KU, Pittelkow MR, Wood JM (1986) Free radical reduction by Thioredoxin reductase at the surface of normal and vitiliginous human keratinocytes. J Invest Dermatol 87:728–732.

    Article  PubMed  CAS  Google Scholar 

  43. Smyth TR Jr, Boissy RE, Fite KV (1981) The DAM chicken: a model for spontaneous postnatal cutaneous and ocular amelanosis. J Hered 72:150–156.

    PubMed  Google Scholar 

  44. Suvanprakorn P, Dee-Analap S, Pongsomboon C, Klaus SN (1985) Melanocyte autologous grafting for treatment of leukoderma. J Am Acad Dermatol 13:968–974.

    Article  PubMed  CAS  Google Scholar 

  45. Symposium (1986) Management of vitiligo in children. Ped Dermatol 3:498–510.

    Article  Google Scholar 

  46. Szekeres E, Morvay M (1985) Repigmentation of vitiligo macules treated topically with Efudix* cream. Dermatologica 171:55–59.

    Article  PubMed  CAS  Google Scholar 

  47. Takei M, Mishima Y, Muda H (1984) Immunopathology of vitiligo vulgaris, Sutton’s leukoderma and melanoma-associated vitiligo in relation to steroid effects. I. Circulating antibodies for cultured melanoma cells. J Cut Pathol 11:107–113.

    Article  CAS  Google Scholar 

  48. Tosti A, Bardazzi F, Depadova MP, Veronesi S, Bergonzoni C (1986) Deafness and vitiligo in an Italian family. Dermatologica 172:178–179.

    Article  PubMed  CAS  Google Scholar 

  49. Tsuji T, Hamada T (1983) Topically administered fluorouracil in vitiligo. Arch Dermatol 119:722–727.

    Article  PubMed  CAS  Google Scholar 

  50. Uda H, Takei M, Mishima Y (1984) Immunopathology of vitiligo vulgaris, Sutton’s leukoderma and melanoma-associated vitiligo in relation to steroid effects. II. The IgG and C3 deposits in the skin. J Cut Pathol 11:114–124.

    Article  CAS  Google Scholar 

  51. Uehara M, Miyauchi H, Tanaka S (1984) Diminished contact sensitivity response in vitiliginous skin. Arch Dermatol 120:195–198.

    Article  PubMed  CAS  Google Scholar 

  52. Wagoner MD, Albert DM, Lerner AB, Kirkwood J, Forget BM, Nordlund JJ (1983) New observations on vitiligo and ocular disease. Am J Ophthalmology 96:16–26.

    CAS  Google Scholar 

  53. Westerhof W, Groot I, Krieg SR, Bos JD, Cormane RH (1986) Langerhans’ cell population with OKT 6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral Phenylalanine loading and UVA irradiation. Acta Derm Venereol 66:259–261.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Nice, Hôpital Pasteur, Nice, France

    J. P. Ortonne

Authors
  1. J. P. Ortonne
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Hautklinik und Poliklinik, Klinikum Steglitz der Freien Universität, Hindenburgdamm 30, D-1000, Berlin 45, Federal Republic of Germany

    Constantin E. Orfanos (CMD — Scientific Secretariat), Rudolf Stadler (CMD — Scientific Secretariat) & Harald Gollnick (CMD — Scientific Secretariat) (CMD — Scientific Secretariat),  (CMD — Scientific Secretariat) &  (CMD — Scientific Secretariat)

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Ortonne, J.P. (1988). Vitiligo. In: Orfanos, C.E., Stadler, R., Gollnick, H. (eds) Dermatology in Five Continents. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83360-1_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-83360-1_30

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-83362-5

  • Online ISBN: 978-3-642-83360-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation